These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8187482)

  • 1. Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders.
    Rosenthal RN; Hellerstein DJ; Miner CR
    Compr Psychiatry; 1994; 35(2):91-8. PubMed ID: 8187482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patterns.
    Rosenthal RN; Hellerstein DJ; Miner CR
    Psychiatr Q; 1992; 63(1):3-26. PubMed ID: 1438603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug use and dependence in schizophrenia].
    Arias Horcajadas F; Padín Calo JJ; Fernández González MA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(6):379-89. PubMed ID: 9477606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are positive and negative symptoms relevant to cross-sectional diagnosis of schizophrenic and schizoaffective patients?
    Cuesta MJ; Peralta V
    Compr Psychiatry; 1995; 36(5):353-61. PubMed ID: 7497709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self reports of the interaction between substance abuse and schizophrenia.
    Baigent M; Holme G; Hafner RJ
    Aust N Z J Psychiatry; 1995 Mar; 29(1):69-74. PubMed ID: 7625979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
    Dixon L; Haas G; Weiden PJ; Sweeney J; Frances AJ
    Am J Psychiatry; 1991 Feb; 148(2):224-30. PubMed ID: 1987823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.
    Wilens TE; Biederman J; Mick E; Faraone SV; Spencer T
    J Nerv Ment Dis; 1997 Aug; 185(8):475-82. PubMed ID: 9284860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of substance-induced psychosis and schizophrenia in patients with substance use disorders.
    Rosenthal RN; Miner CR
    Schizophr Bull; 1997; 23(2):187-93. PubMed ID: 9165629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use and other psychiatric disorders among 100 American Indian patients.
    Westermeyer J; Neider J; Westermeyer M
    Cult Med Psychiatry; 1992-1993; 16(4):519-29. PubMed ID: 1305530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder.
    Potvin S; Pampoulova T; Mancini-Marië A; Lipp O; Bouchard RH; Stip E
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):796-8. PubMed ID: 16705205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of substance abuse on the course and outcome of schizophrenia.
    Turner WM; Tsuang MT
    Schizophr Bull; 1990; 16(1):87-95. PubMed ID: 2185537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
    Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
    Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of positive and negative symptoms to cocaine abuse in schizophrenia.
    Lysaker P; Bell M; Beam-Goulet J; Milstein R
    J Nerv Ment Dis; 1994 Feb; 182(2):109-12. PubMed ID: 8308528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of mental and substance use disorders. A comparison of single and dual diagnosis patients.
    Lehman AF; Myers CP; Thompson JW; Corty E
    J Nerv Ment Dis; 1993 Jun; 181(6):365-70. PubMed ID: 8388914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathology in patients with schizophrenia and substance abuse: a comparative clinical study.
    Krausz M; Mass R; Haasen C; Gross J
    Psychopathology; 1996; 29(2):95-103. PubMed ID: 8861513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrecognized cocaine use among schizophrenic patients.
    Shaner A; Khalsa ME; Roberts L; Wilkins J; Anglin D; Hsieh SC
    Am J Psychiatry; 1993 May; 150(5):758-62. PubMed ID: 8480822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of recent cocaine use on patients with acute schizophrenia.
    Serper MR; Alpert M; Richardson NA; Dickson S; Allen MH; Werner A
    Am J Psychiatry; 1995 Oct; 152(10):1464-9. PubMed ID: 7573585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.